Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more production. They pledged this to Gavi. Bharat Biotech invested over $200 million to boost production. Twelve African countries will use the vaccine by 2025. This aims to help millions of children and families.
Categories
Finance/Money
Bharat Biotech, GSK to slash malaria vaccine price
